Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers.
OBJECTIVE
To compare the rate of healing of diabetic neuropathic ulcers using cultured autologous keratinocytes delivered on chemically defined transfer discs (Myskin) (active treatment) versus healing obtained with cell-free discs (placebo).


METHODS
After a 4-week lead-in period patients (randomly assigned) received active or placebo treatments weekly for 6 weeks. All patients then received active treatments for a maximum of 12 treatments where required. Altogether, 16 patients with a total of 21 ulcers resistant to conventional therapy were recruited from four specialist diabetic centers in three cities.


RESULTS
All 21 ulcers were treated and of these ten healed and eight improved, with two failing to respond (one ulcer was lost due to autoamputation). For analysis according to the study criteria, however, only the 12 patients with 12 index ulcers who completed treatment protocols were eligible - five in the placebo group and seven in the active group. Of these, five ulcers healed completely and seven were reduced by more than 50%. Complete healing took a median of ten active applications.


CONCLUSIONS
Repeated regular applications of the patient's keratinocytes, delivered on the carrier dressing, initiated wound healing in ulcers resistant to conventional therapy, with 18 out of 21 ulcers responding. The healing observed did not appear attributable to patient recruitment or the cell-free carrier dressing but to the delivery of the cultured cells.
Moustafa
Manar
M
Northern General Hospital, Division of Clinical Sciences (North), School of Medicine, Sheffield, S5 7AU, UK.
Bullock
Anthony J
AJ
Creagh
Fionuala M
FM
Heller
Simon
S
Jeffcoate
William
W
Game
Frances
F
Amery
Carol
C
Tesfaye
Soloman
S
Ince
Zoe
Z
Haddow
David B
DB
MacNeil
Sheila
S
D000328:Adult; D000368:Aged; D001458:Bandages; D002460:Cell Line; D017719:Diabetic Foot / Q000473:pathology* / Q000628:therapy*; D018450:Disease Progression; D005260:Female; D006801:Humans; D015603:Keratinocytes / Q000166:cytology*; D007871:Leg Ulcer / Q000473:pathology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016037:Single-Blind Method; D016896:Treatment Outcome; D014945:Wound Healing